Displaying drugs 15176 - 15200 of 15318 in total
1-(4-HEXYLPHENYL)PROP-2-EN-1-ONE
Experimental
2,6-dibromo-4-phenoxyphenol
Experimental
2-(3-BENZOYLPHENOXY)ETHYL(HYDROXY)FORMAMIDE
Experimental
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole
5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole is a solid. This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. 5-(5-(2,6-dichloro-4-(4,5-dihydro-2-oxazolyl)phenoxy)pentyl)-3-(hydroxyethyl oxymethyleneoxymethyl) isoxazole targets the protein genome polyprotein.
Experimental
2-(4-METHOXYPHENYL)ACETAMIDE
Experimental
4-(2-AMINOETHYL)BENZENESULFONAMIDE
Experimental
Chlorproguanil
Chlorproguanil has been used in trials studying the treatment of MALARIA. It is a dichloro-derivative of chloroguanide.
Investigational
Tolpropamine
Experimental
Eprozinol
Experimental
Etybenzatropine
Experimental
Carbuterol
Experimental
Quifenadine
Experimental
Aluminium clofibrate
Experimental
Xipamide
Experimental
Haloxazolam
Experimental
Illicit
Mosapramine
Experimental
XMT-1001
XMT-1001 is a polymer-based prodrug of camptothecin (CPT), a well-characterized topoisomerase I inhibitor with potent anti-tumor activity. It is a water-soluble macromolecular conjugate of camptothecin (CPT). In this novel CPT pro-drug, CPT is conjugated with a 70 kDa biodegradable hydrophilic polyacetal, poly (1-hydroxymethylene hydroxylmethylformal). XMT-1001 has demonstrated an improved therapeutic...
Investigational
Matched Description: … XMT-1001 has demonstrated an improved therapeutic window as compared with CPT and irinotecan in human …
2-((4'-HYDROXYPHENYL)-AZO)BENZOIC ACID
Experimental
Displaying drugs 15176 - 15200 of 15318 in total